Ask Me Anything w/ Christina Farr (Second Opinion) and Blake Madder (Hospitalogy)
What is driving the next major shift in healthcare? In the wrap-up of this session, Blake and Christina look past the legacy tech debate to focus on the explosive growth within pharmaceutical verticals.
Every few years, a new pocket of healthcare takes center stage—where the COVID era was dominated by the rise of value-based care, the current frontier is all about specialty drugs, oncology, 340B programs, and vertical integration among drug distributors. The team breaks down why this area is seeing rapid change, answers a few final audience thoughts, and shares how to get in touch to keep the conversation going.
Key Takeaways
- The Specialty Drug Boom: Shifting focus from general care models to the massive growth happening in specialty drugs, oncology, and complex pharmaceutical supply chains.
- Vertical Integration: How drug distributor integration and 340B program changes are creating a high-stakes, rapidly evolving environment in healthcare.
- The 5-Year Healthcare Cycle: A look at how healthcare focus areas cyclically rotate—transitioning from the value-based care wave of recent years into today’s pharmacy-driven market.
More Webinars
View all →
Verifying AI in Medicine: Is Healthcare AI Actually Ready for Deployment?
Is AI ready for real-world clinical care? Dr. Zak Kohane and Protege’s Engy Ziedan debate what it takes to safely trust AI in diagnosis and treatment, from benchmark performance and clinical evidence to whether we’re holding AI to a higher standard than humans.
Why Are Hospitals Hiring Chief AI Officers?
As AI moves from pilots into day-to-day healthcare operations, health systems are having to decide who should actually own the